NCT00964197

Brief Summary

FemmeJock is a pelvic floor support system developed by pelvic floor physiotherapists for patients with pelvic organ prolapse in order to ameliorate symptoms of pelvic floor pressure and discomfort. The device is a girdle to be worn on the outside of underwear. The device is machine washable and there are no documented risks with wearing it. This product is currently being used by pelvic floor physiotherapists and has been subjectively reported by individual accounts as being successful in improving pelvic floor symptoms. The efficacy of this product has not been previously studied in women with pelvic organ prolapse. The investigators are proposing a pilot study with the following specific aims:

  1. 1.to assess patient satisfaction and continuation of use of the FemmeJock support system after 3 months of treatment.
  2. 2.to describe, if any, the reasons for discontinuation associated with the use of this product, and
  3. 3.to assess whether women experience improvement of pelvic floor symptoms after using this product.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

July 17, 2009

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 24, 2009

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

March 5, 2021

Status Verified

March 1, 2021

Enrollment Period

5.4 years

First QC Date

July 17, 2009

Last Update Submit

March 4, 2021

Conditions

Keywords

FemmeJockPelvic Organ Prolapse

Outcome Measures

Primary Outcomes (1)

  • to assess patient satisfaction and continuation of use of the FemmeJock support system after 3 months of treatment.

    2 years

Secondary Outcomes (2)

  • To describe, if any, the reasons for discontinuation associated with the use of this product.

    2 years

  • To assess whether women experience improvement of pelvic floor symptoms after using this product.

    2 years

Study Arms (1)

FemmeJock

EXPERIMENTAL

The participant will be fitted with the girdle. The participant will use the girdle for the next 3 months. The girdle is only to be worn during the daytime during times of physical activity. The length of time you choose to wear it during the day is the patients choice. In two weeks the participant will be asked to fill out a 5 question survey in a follow up visit. The participant will be asked to return 3 months after wearing the FemmeJock girdle and to fill out a 5 question survey, as well as to complete a 20 question survey.

Device: FemmeJock

Interventions

FemmeJockDEVICE

The participant will be fitted with the girdle. The participant will use the girdle for the next 3 months. The girdle is only to be worn during the daytime during times of physical activity. The length of time you choose to wear it during the day is the patients choice. In two weeks the participant will be asked to fill out a 5 question survey in a follow up visit. The participant will be asked to return 3 months after wearing the FemmeJock girdle and to fill out a 5 question survey, as well as to complete a 20 question survey.

FemmeJock

Eligibility Criteria

Age18 Years - 99 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pelvic organ prolapse, \> stage II
  • or more prolapse associated symptoms:
  • Herniation symptoms
  • Pelvic pressure
  • Bulging tissue
  • Sexual dysfunction
  • Patient willingness to enroll
  • Available for 3 months of follow-up

You may not qualify if:

  • Pregnancy or planning pregnancy within the next 3 months
  • Perineal ulcers or trauma
  • Anticipating relocation in next 3 months
  • Current pessary use
  • Dementia or inability to complete questionnaires
  • Chronic inflammatory or infectious vulvar condition (i.e., dermatologic conditions: lichen sclerosis or lichen planus, or vulvar candidiasis)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, 73104, United States

Location

MeSH Terms

Conditions

Pelvic Organ Prolapse

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Lieschen H. Quiroz, M.D.

    University of Oklahoma

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2009

First Posted

August 24, 2009

Study Start

November 1, 2008

Primary Completion

April 1, 2014

Study Completion

April 1, 2014

Last Updated

March 5, 2021

Record last verified: 2021-03

Locations